yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q30275646-4081412E-EB09-4678-99F4-03AA4D55F94F
Q30275646-4081412E-EB09-4678-99F4-03AA4D55F94F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30275646-4081412E-EB09-4678-99F4-03AA4D55F94F
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
P2860
Q30275646-4081412E-EB09-4678-99F4-03AA4D55F94F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30275646-4081412E-EB09-4678-99F4-03AA4D55F94F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00cf896b34f4d73e6fd53e715c552bf9b85bc3e0
P2860
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma.